United States Biotechnology & Medical Research

Spring Bank Pharmaceuticals Inc (SBPH)

Ticker: SBPH Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Spring Bank Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Kayitalire Louis Chief Medical Officer Officer
Transaction date
Planned sale
Price
327.92
Quantity 29,357 -28.2%
Value US$4,727,257
Kayitalire Louis Chief Medical Officer Officer
Transaction date
Planned sale
Price
361.42
Quantity 12,530 +10.2%
Value US$273,522
Kayitalire Louis Chief Medical Officer Officer
Transaction date
Planned sale
Price
204.38
Quantity 20,301 -0.3%
Value US$323,604
Driscoll Martin J President and CEO Executive Director
Transaction date
Sale
Price
4.76
Quantity 175 -0.4%
Value US$833
2.2
Firmani Lori VP of Finance and Treasurer Officer
Transaction date
Sale
Price
4.76
Quantity 175 -1.0%
Value US$833
1.8
Winslow Garrett General Counsel and Secretary Officer
Transaction date
Sale
Price
4.76
Quantity 175 -0.9%
Value US$833
Iyer Radhakrishnan P. Chief Scientific Officer Officer
Transaction date
Sale
Price
4.76
Quantity 175 -0.1%
Value US$833
Eichler Kurt M
Transaction date
Sale
Price
1.26
Quantity 40,000 -6.8%
Value US$50,540
1.7
Freve Jonathan CFO & Treasurer
Transaction date
Purchase
Price
3.04
Quantity 5,000 +40.1%
Value US$15,200
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
2.83
Quantity 5,000 +5.9%
Value US$14,150
4.1
Smith Scott Andrew
Transaction date
Purchase
Price
4.09
Quantity 12,000 +637.3%
Value US$49,080
1.7
Freve Jonathan CFO & Treasurer
Transaction date
Purchase
Price
5.40
Quantity 5,000 +66.8%
Value US$27,000
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
6.03
Quantity 10,000 +13.3%
Value US$60,300
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
6.63
Quantity 5,000 +7.1%
Value US$33,150
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
7.36
Quantity 5,000 +7.6%
Value US$36,800
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
7.31
Quantity 5,000 +8.3%
Value US$36,550
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
12.02
Quantity 4,000 +7.1%
Value US$48,080
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
12.83
Quantity 1,000 +1.8%
Value US$12,830
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
14.84
Quantity 1,000 +1.8%
Value US$14,840
Arkowitz David
Transaction date
Purchase
Price
12.24
Quantity 2,300 +13.5%
Value US$28,152
Arkowitz David
Transaction date
Purchase
Price
12.25
Quantity 200 +1.2%
Value US$2,450
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
12.43
Quantity 1,000 +1.9%
Value US$12,430
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
12.28
Quantity 1,000 +1.9%
Value US$12,280
Eichler Kurt M
Transaction date
Purchase
Price
13.00
Quantity 76,923 +15.2%
Value US$999,999
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
9.44
Quantity 2,000 +4.0%
Value US$18,880
Eichler Kurt M
Transaction date
Purchase
Price
8.76
Quantity 1,200 New position
Value US$10,516
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
8.50
Quantity 2,000 +4.1%
Value US$17,000
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
7.98
Quantity 2,000 +4.3%
Value US$15,960
Eichler Kurt M Non-Executive Director
Transaction date
Purchase
Price
8.69
Quantity 7,000 +1.6%
Value US$60,830
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
8.84
Quantity 2,000 +8.9%
Value US$17,680
Eichler Kurt M Non-Executive Director
Transaction date
Purchase
Price
12.50
Quantity 1,346 +0.3%
Value US$16,825
Eichler Kurt M Non-Executive Director
Transaction date
Purchase
Price
12.50
Quantity 650 +0.2%
Value US$8,125
Eichler Kurt M Non-Executive Director
Transaction date
Purchase
Price
12.50
Quantity 514 +0.1%
Value US$6,425
Eichler Kurt M Non-Executive Director
Transaction date
Purchase
Price
12.50
Quantity 490 +0.1%
Value US$6,125
Afdhal Nezam H. Chief Medical Officer Officer
Transaction date
Purchase
Price
12.50
Quantity 2,400 +6.4%
Value US$30,000
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
11.75
Quantity 1,000 +4.7%
Value US$11,750
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
12.41
Quantity 1,000 +4.9%
Value US$12,410
Afdhal Nezam H. Chief Medical Officer Officer
Transaction date
Purchase
Price
12.00
Quantity 350 +0.9%
Value US$4,200
Afdhal Nezam H. Chief Medical Officer Officer
Transaction date
Purchase
Price
11.99
Quantity 100 +0.3%
Value US$1,199
Afdhal Nezam H. Chief Medical Officer Officer
Transaction date
Purchase
Price
11.90
Quantity 1,550 +4.3%
Value US$18,445
Eichler Kurt M Non-Executive Director
Transaction date
Purchase
Price
10.73
Quantity 3,000 +0.7%
Value US$32,190
Freve Jonathan CFO, Treasurer & Secretary Officer
Transaction date
Purchase
Price
10.74
Quantity 1,000 +100.0%
Value US$10,740
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
11.66
Quantity 1,000 +5.1%
Value US$11,660
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
11.20
Quantity 1,000 +5.4%
Value US$11,200
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
11.37
Quantity 1,000 +5.7%
Value US$11,370
Afdhal Nezam H. Chief Medical Officer Officer
Transaction date
Purchase
Price
11.49
Quantity 100 +0.3%
Value US$1,149
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
11.20
Quantity 1,000 +6.1%
Value US$11,200
Afdhal Nezam H. Chief Medical Officer Officer
Transaction date
Purchase
Price
11.43
Quantity 1,800 +5.3%
Value US$20,574
Afdhal Nezam H. Chief Medical Officer Officer
Transaction date
Purchase
Price
11.33
Quantity 2,600 +8.3%
Value US$29,450
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
11.11
Quantity 1,000 +6.5%
Value US$11,110
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
10.94
Quantity 1,000 +6.9%
Value US$10,940
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
10.15
Quantity 1,000 +7.4%
Value US$10,150
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
9.77
Quantity 1,000 +8.0%
Value US$9,770
Freve Jonathan CFO, Treasurer & Secretary Officer
Transaction date
Purchase
Price
9.75
Quantity 1,000 New position
Value US$9,750
Eichler Kurt M Non-Executive Director
Transaction date
Purchase
Price
9.79
Quantity 1,000 +0.2%
Value US$9,790
Driscoll Martin J President and CEO Executive Director
Transaction date
Purchase
Price
12.00
Quantity 12,500 New position
Value US$150,000
Eichler Kurt M Non-Executive Director
Transaction date
Purchase
Price
12.00
Quantity 41,666 +10.9%
Value US$499,992
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-04 2021-11-02 PlS Planned sale
Kayitalire Louis

Chief Medical Officer

Officer
29,357 -28.2%
327.92
US$4,727,257 		29,357 -28.2% 327.92 US$4,727,257
2021-11-04 2021-11-02 PlS Planned sale
Kayitalire Louis

Chief Medical Officer

Officer
12,530 +10.2%
361.42
US$273,522 		12,530 +10.2% 361.42 US$273,522
2021-10-06 2021-10-04 PlS Planned sale
Kayitalire Louis

Chief Medical Officer

Officer
20,301 -0.3%
204.38
US$323,604 		20,301 -0.3% 204.38 US$323,604
2020-11-23 2020-11-20 S Sale
Driscoll Martin J

President and CEO

Executive Director
175 -0.4%
4.76
US$833 		175 -0.4% 4.76 US$833
2020-11-23 2020-11-20 S Sale
2.2
Firmani Lori

VP of Finance and Treasurer

Officer
175 -1.0%
4.76
US$833 		175 -1.0% 4.76 US$833
2020-11-23 2020-11-20 S Sale
1.8
Winslow Garrett

General Counsel and Secretary

Officer
175 -0.9%
4.76
US$833 		175 -0.9% 4.76 US$833
2020-11-23 2020-11-20 S Sale
Iyer Radhakrishnan P.

Chief Scientific Officer

Officer
175 -0.1%
4.76
US$833 		175 -0.1% 4.76 US$833
2020-01-02 2019-12-30 S Sale
Eichler Kurt M
40,000 -6.8%
1.26
US$50,540 		40,000 -6.8% 1.26 US$50,540
2019-11-14 2019-11-14 B Purchase
1.7
Freve Jonathan

CFO & Treasurer
5,000 +40.1%
3.04
US$15,200 		5,000 +40.1% 3.04 US$15,200
2019-11-14 2019-11-13 B Purchase
Driscoll Martin J

President and CEO

Executive Director
5,000 +5.9%
2.83
US$14,150 		5,000 +5.9% 2.83 US$14,150
2019-06-28 2019-06-28 B Purchase
4.1
Smith Scott Andrew
12,000 +637.3%
4.09
US$49,080 		12,000 +637.3% 4.09 US$49,080
2019-05-29 2019-05-29 B Purchase
1.7
Freve Jonathan

CFO & Treasurer
5,000 +66.8%
5.40
US$27,000 		5,000 +66.8% 5.40 US$27,000
2019-05-29 2019-05-29 B Purchase
Driscoll Martin J

President and CEO

Executive Director
10,000 +13.3%
6.03
US$60,300 		10,000 +13.3% 6.03 US$60,300
2019-05-22 2019-05-21 B Purchase
Driscoll Martin J

President and CEO

Executive Director
5,000 +7.1%
6.63
US$33,150 		5,000 +7.1% 6.63 US$33,150
2019-04-30 2019-04-30 B Purchase
Driscoll Martin J

President and CEO

Executive Director
5,000 +7.6%
7.36
US$36,800 		5,000 +7.6% 7.36 US$36,800
2019-04-30 2019-04-30 B Purchase
Driscoll Martin J

President and CEO

Executive Director
5,000 +8.3%
7.31
US$36,550 		5,000 +8.3% 7.31 US$36,550
2018-08-13 2018-08-13 B Purchase Driscoll Martin J

President and CEO

Executive Director
4,000 +7.1%
12.02
US$48,080 		4,000 +7.1% 12.02 US$48,080
2018-03-01 2018-02-28 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +1.8%
12.83
US$12,830 		1,000 +1.8% 12.83 US$12,830
2017-09-14 2017-09-14 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +1.8%
14.84
US$14,840 		1,000 +1.8% 14.84 US$14,840
2017-08-07 2017-08-04 B Purchase Arkowitz David
2,300 +13.5%
12.24
US$28,152 		2,300 +13.5% 12.24 US$28,152
2017-08-07 2017-08-04 B Purchase Arkowitz David
200 +1.2%
12.25
US$2,450 		200 +1.2% 12.25 US$2,450
2017-08-03 2017-08-03 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +1.9%
12.43
US$12,430 		1,000 +1.9% 12.43 US$12,430
2017-08-03 2017-08-03 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +1.9%
12.28
US$12,280 		1,000 +1.9% 12.28 US$12,280
2017-06-27 2017-06-27 B Purchase Eichler Kurt M
76,923 +15.2%
13.00
US$999,999 		76,923 +15.2% 13.00 US$999,999
2017-03-07 2017-03-07 B Purchase Driscoll Martin J

President and CEO

Executive Director
2,000 +4.0%
9.44
US$18,880 		2,000 +4.0% 9.44 US$18,880
2017-02-27 2017-02-23 B Purchase Eichler Kurt M
1,200 New position
8.76
US$10,516 		1,200 New position 8.76 US$10,516
2016-12-16 2016-12-15 B Purchase Driscoll Martin J

President and CEO

Executive Director
2,000 +4.1%
8.50
US$17,000 		2,000 +4.1% 8.50 US$17,000
2016-12-01 2016-11-30 B Purchase Driscoll Martin J

President and CEO

Executive Director
2,000 +4.3%
7.98
US$15,960 		2,000 +4.3% 7.98 US$15,960
2016-11-10 2016-11-09 B Purchase Eichler Kurt M Non-Executive Director
7,000 +1.6%
8.69
US$60,830 		7,000 +1.6% 8.69 US$60,830
2016-11-10 2016-11-09 B Purchase Driscoll Martin J

President and CEO

Executive Director
2,000 +8.9%
8.84
US$17,680 		2,000 +8.9% 8.84 US$17,680
2016-09-20 2016-09-19 B Purchase Eichler Kurt M Non-Executive Director
1,346 +0.3%
12.50
US$16,825 		1,346 +0.3% 12.50 US$16,825
2016-09-20 2016-09-16 B Purchase Eichler Kurt M Non-Executive Director
650 +0.2%
12.50
US$8,125 		650 +0.2% 12.50 US$8,125
2016-09-15 2016-09-14 B Purchase Eichler Kurt M Non-Executive Director
514 +0.1%
12.50
US$6,425 		514 +0.1% 12.50 US$6,425
2016-09-14 2016-09-13 B Purchase Eichler Kurt M Non-Executive Director
490 +0.1%
12.50
US$6,125 		490 +0.1% 12.50 US$6,125
2016-09-12 2016-09-09 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
2,400 +6.4%
12.50
US$30,000 		2,400 +6.4% 12.50 US$30,000
2016-09-02 2016-09-02 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +4.7%
11.75
US$11,750 		1,000 +4.7% 11.75 US$11,750
2016-08-31 2016-08-30 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +4.9%
12.41
US$12,410 		1,000 +4.9% 12.41 US$12,410
2016-08-24 2016-08-24 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
350 +0.9%
12.00
US$4,200 		350 +0.9% 12.00 US$4,200
2016-08-24 2016-08-24 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
100 +0.3%
11.99
US$1,199 		100 +0.3% 11.99 US$1,199
2016-08-24 2016-08-24 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
1,550 +4.3%
11.90
US$18,445 		1,550 +4.3% 11.90 US$18,445
2016-08-24 2016-08-23 B Purchase Eichler Kurt M Non-Executive Director
3,000 +0.7%
10.73
US$32,190 		3,000 +0.7% 10.73 US$32,190
2016-08-23 2016-08-23 B Purchase Freve Jonathan

CFO, Treasurer & Secretary

Officer
1,000 +100.0%
10.74
US$10,740 		1,000 +100.0% 10.74 US$10,740
2016-08-22 2016-08-22 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +5.1%
11.66
US$11,660 		1,000 +5.1% 11.66 US$11,660
2016-08-22 2016-08-19 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +5.4%
11.20
US$11,200 		1,000 +5.4% 11.20 US$11,200
2016-08-16 2016-08-16 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +5.7%
11.37
US$11,370 		1,000 +5.7% 11.37 US$11,370
2016-08-16 2016-08-16 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
100 +0.3%
11.49
US$1,149 		100 +0.3% 11.49 US$1,149
2016-08-16 2016-08-15 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +6.1%
11.20
US$11,200 		1,000 +6.1% 11.20 US$11,200
2016-08-16 2016-08-15 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
1,800 +5.3%
11.43
US$20,574 		1,800 +5.3% 11.43 US$20,574
2016-08-15 2016-08-12 B Purchase Afdhal Nezam H.

Chief Medical Officer

Officer
2,600 +8.3%
11.33
US$29,450 		2,600 +8.3% 11.33 US$29,450
2016-08-09 2016-08-09 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +6.5%
11.11
US$11,110 		1,000 +6.5% 11.11 US$11,110
2016-08-09 2016-08-09 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +6.9%
10.94
US$10,940 		1,000 +6.9% 10.94 US$10,940
2016-08-05 2016-08-04 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +7.4%
10.15
US$10,150 		1,000 +7.4% 10.15 US$10,150
2016-08-05 2016-08-04 B Purchase Driscoll Martin J

President and CEO

Executive Director
1,000 +8.0%
9.77
US$9,770 		1,000 +8.0% 9.77 US$9,770
2016-08-05 2016-08-04 B Purchase Freve Jonathan

CFO, Treasurer & Secretary

Officer
1,000 New position
9.75
US$9,750 		1,000 New position 9.75 US$9,750
2016-08-05 2016-08-04 B Purchase Eichler Kurt M Non-Executive Director
1,000 +0.2%
9.79
US$9,790 		1,000 +0.2% 9.79 US$9,790
2016-05-12 2016-05-11 B Purchase Driscoll Martin J

President and CEO

Executive Director
12,500 New position
12.00
US$150,000 		12,500 New position 12.00 US$150,000
2016-05-12 2016-05-11 B Purchase Eichler Kurt M Non-Executive Director
41,666 +10.9%
12.00
US$499,992 		41,666 +10.9% 12.00 US$499,992
Explore more

More insider trading research around Spring Bank Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America